OKLAHOMA CITY, OK--(Marketwire - Feb 7, 2013) - On February 1, 2013, a class action lawsuit was filed in the District Court for Harris County, Texas against Keryx Biopharmaceuticals, Inc. (
On January 29, 2013, the Company announced an agreement to sell to KMP. Under the terms of the agreement, Copano shareholders will receive 0.4563 of a KMP share for each share of Copano they own, representing a value of approximately $40.91 a share. The transaction has a total approximate value of $5 billion, including the assumption of debt.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
- Company Legal & Law Matters